Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advancing the regulation of medical devices with regulatory science

This article was originally published in Clinica

Executive Summary

Advances in medical technologies mean authorities are now coming across new products which cannot be adequately regulated by existing systems. Dr Gabriel Adusei, founder of the International Association of MedTech Consultants, discusses how applying the principles of regulatory science can enable regulators to meet these challenges

You may also be interested in...

How to improve post-market surveillance on a global scale

In the EU, the European Commission is encouraging member states to increase the exchange of National Competent Authorities Reports (NCARs). Its staff working document on the impact assessment on the revision of the regulatory framework for medical devices - published in September 2012 - also encourages them to share knowledge and competencies. In this article, Gabriel Adusei* makes a series of recommendations that could improve market surveillance and vigilance not only in the EU, but globally

Strengthening the medical device quality standard EN ISO 13485:2012

Gabriel Adusei suggests how shortcomings in the quality standard for medical devices might be fixed.

Sticking plasters on chronic wounds: time to strengthen EN ISO 13485:2012

As medical technology advances, regulations become more stringent, and standards must adapt to reflect the regulatory advances. But one of the most critical to the medtech industry is failing to keep up with regulatory progress in the EU and is becoming outdated. In this article, independent medtech consultant Gabriel Adusei argues why the sticking plaster approach to the EU quality management system standard is not enough





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts